← Leaderboards
Jeremy William Gordon
University Of California, San Francisco
$6,602,958
Attributed
$14,539,298
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,539,298 · 5
By mechanism
R01$7,968,581 · 4
U01$6,570,717 · 1
Top collaborators
- Daniel B Vigneron9 shared
- Yan Li4 shared
- Javier Villanueva-Meyer4 shared
- David M Wilson3 shared
- Ari J Green2 shared
- Zhen Jane Wang2 shared
- Myriam Marianne Chaumeil1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Zhen Jane Wang$4,501,373
- Peder Eric Zufall Larson$7,557,566
- Daniel B Vigneron$43,424,992
- Ajit Harishkumar Goenka$3,380,410
- Sabrina Miriam Ronen$18,398,578
Others in their field
Other Emerging Leaders on “Magnetic Resonance Imaging”
- Susan Abushakra · Alzheon, Inc.$50,765,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Eric C Palm · Florida State University$31,951,397
- Michael W Rabin · Florida State University$26,502,247
- Ross D McDonald · Florida State University$26,502,247
- Bryan Roth · Univ Of North Carolina Chapel Hill$21,325,531
Research focus
Magnetic Resonance ImagingImageClinical ResearchMetabolismMonitorResponseTreatment ResponseMetabolic ImagingMetabolicClinical ManagementPyruvateEvaluationPre-ClinicalAlzheimer&AposUnited States National Institutes Of HealthImaging ApproachReproducibilityMolecular ImagingSuccessImaging ModalityStable IsotopeInterestFutureTranslations
Grant awards (20)
Multimodality Neuroimaging Evaluation of Cognitive Functioning in Lower Grade Astrocytoma$1,334,513
R01 · FY2025 · CA
Imaging cerebral metabolic impairment in AD using Deuterium MRI$670,365
R01 · FY2025 · AG · contact PI
Translating Hyperpolarized 13C MRI as a Novel Tool to Predict Treatment Response in Pancreatic Cancer$670,223
R01 · FY2025 · CA · contact PI
Imaging cerebral metabolic impairment in AD using Deuterium MRI$685,840
R01 · FY2024 · AG · contact PI
Translating Hyperpolarized 13C MRI as a Novel Tool to Predict Treatment Response in Pancreatic Cancer$670,223
R01 · FY2024 · CA · contact PI
Multimodality Neuroimaging Evaluation of Cognitive Functioning in Lower Grade Astrocytoma$633,896
R01 · FY2024 · CA
MR Metabolic Imaging of Multiple Sclerosis$626,409
R01 · FY2024 · NS · contact PI
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,201,901
U01 · FY2023 · EB
Imaging cerebral metabolic impairment in AD using Deuterium MRI$719,216
R01 · FY2023 · AG
Multimodality Neuroimaging Evaluation of Cognitive Functioning in Lower Grade Astrocytoma$653,911
R01 · FY2023 · CA
MR Metabolic Imaging of Multiple Sclerosis$645,373
R01 · FY2023 · NS · contact PI
Supplement for Development and Translation of Specialized Hyperpolarized C-13 MRI Methods for Alzheimer's Disease$403,750
U01 · FY2023 · EB
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,203,327
U01 · FY2022 · EB
Multimodality Neuroimaging Evaluation of Cognitive Functioning in Lower Grade Astrocytoma$658,612
R01 · FY2022 · CA
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$38,229
U01 · FY2022 · EB
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,180,441
U01 · FY2021 · EB
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$85,819
U01 · FY2021 · EB
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,204,018
U01 · FY2020 · EB
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$38,229
U01 · FY2020 · EB
Development and Translation of Hyperpolarized C-13 Prostate Cancer MRI Methods$1,215,003
U01 · FY2019 · EB